Industry Renews Call for Perpetual Introduction of Premium for New Drug Development: CSIMC Expert Subcommittee

Industry Representatives Attend Expert Subcommittee Meeting At a meeting of the Central Social Insurance Medical Council’s (CSIMC; Chuikyo ) Expert Subcommittee on NHI Drug Pricing Affairs, the subcommittee members verified the impact of the“premium for the development of new drugs...read more